Dammarane triterpenoids for pharmaceutical use: a patent review (2005 – 2014)

Bibliography

• Kim DH. Chemical diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng. J Ginseng Res 2012;36(1):1-15
   PubMed Web of Science ®Google Scholar
• Yang WZ, Hu Y, Wu WY, et al. Saponins in the genus Panax L. (Araliaceae): a systematic review of their chemical diversity. Phytochemistry 2014;106:7-24
   PubMed Web of Science ®Google Scholar
• Connolly JD, Hill RA. Triterpenoids. Nat Prod Rep 2003;20(6):640-59
   Google Scholar
• Connolly JD, Hill RA. Triterpenoids. Nat Prod Rep 2008;25(4):794-830
   Google Scholar
• Dinda B, Debnath S, Mohanta B, et al. Naturally occurring triterpenoid saponins. Chem Biodivers 2010;7(10):2327-580
   PubMed Web of Science ®Google Scholar
• Razmovski-Naumovski V, Huang TH, VanHoanTran G, et al. Chemistry and pharmacology of Gynostemma pentaphyllum. Phytochem Rev 2005;4(2-3):197-219
   Google Scholar
• Jia L, Zhao YQ, Liang XJ. Current evaluation of the millennium phytomedicine ginseng (II): collected chemical entities, modern pharmacology, and clinical applications emanated from traditional Chinese medicine. Curr Med Chem 2009;16:2924-42
   PubMed Web of Science ®Google Scholar
• Kuo RY, Qian K, Morris-Natschke SL, et al. Plant-derived triterpenoids and analogues as antitumor and anti-HIV agents. Nat Prod Rep 2009;26(10):1321-44
   PubMed Web of Science ®Google Scholar
• Man SL, Gao WY, Zhang YJ, et al. Chemical study and medical application of saponins as anticancer agents. Fitoterapia 2010;81(7):703-14
   PubMed Web of Science ®Google Scholar
• Huang W, Jia W. Use of ginsenosides rh2 & rg3, and aglycon ginsenosides for the prevention of cancer. WO034963A1; 2005
   Google Scholar
• Jung YS, Choi JW. Method for preparing processed ginseng to obtain increased amount of ginsenoside RG5. US0228430A1; 2006
   Google Scholar
• Huang D. Compositions for cancer therapy saponins or sapogenins. US013897A1; 2006
   Google Scholar
• Xiuming C, Chen JJ, Li JM, et al. Panax notoginseng standard extract P1237, pharmaceutical composition containing the same, its preparation and application in cancer therapy. CN101244105A; 2008
   Google Scholar
• Chen B, Xiaobin JIA. Application of ginsenoside rg6 in preparation of medicine for treating lymphoma. CN103230406A; 2013
   Google Scholar
• Chen B, Xiaobin JIA. Application of ginsenoside F4 as only active component in preparing drug for treating malignant lymphoma. CN103202850A; 2013
   Google Scholar
• Li PY, Han L, Zheng Q, et al. Pseudo-ginsenoside RT6, its extraction method and medical use. CN103193848A; 2013
   Google Scholar
• Wang W, Zhao Y, Rayburn ER, et al. In vitro anticancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol 2007;59:589-601
   PubMed Web of Science ®Google Scholar
• Zhao YQ, Zhang RW, Wang W, et al. Method for manufacturing new ginsenoside aglycon derivative formulation used as antitumor agent. CN1939311A; 2007
   Google Scholar
• Zhang RW, Wang W, Wang H, et al. Novel ginsenoside compounds, compositions, and methods of use. WO076900A1; 2008
   Google Scholar
• Zhang RW, Wang W, Zhao YQ. Novel ginsenoside compounds, compositions and methods of use. WO076900A1; 2008
   Google Scholar
• Zhao YQ, Wu CF, Zhang RW, et al. Application of sapogenins of ginsenosides in preparing antitumor agent. CN101234117A; 2008
   Google Scholar
• Zhao YQ, Wu CF, Zhang RW, et al. Application of two PPD derivatives and their mixture in treating and preventing malignant tumor. CN101229175A; 2008
   Google Scholar
• Sun BS, Zhao YQ, Zhao JM, et al. Method for preparation of two ginsengenin and their mixture. CN101245089A; 2008
   Google Scholar
• Zhao YQ, Liu ZY, Cao JQ. Method for preparation of antineoplastic dammarane derivatives from panaxadiol. CN101538305A; 2009
   Google Scholar
• Zhao YQ, Zhang RW, Wang W, et al. Antitumor application of PPD derivative. CN101199534A; 2008
   Google Scholar
• Meng Q, Yin JY, Liu JH, et al. A novel acid degradation product of ginsenoside, its preparation method and medicinal application. CN103965279A; 2014
   Google Scholar
• Wu J. Application of 20(S)-3-methoxy-panaxadiol to antitumor agent. CN103271929A; 2013
   Google Scholar
• Yu L, Zhu HR, Liu ZL, et al. Application of 3β,20(S),21-trihydroxydammaran-24-ene in preparing tumor multidrug resistance reversal agent. CN103446162A; 2013
   Google Scholar
• Huang D, Qi DF. Process for producing dammarane sapogenins and ginsenosides from ginseng and their use as anticancer agents. US0113316A1; 2005
   Google Scholar
• Huang W. Novel dammarane sapogenins and their use as anticancer agents. WO040189A1; 2005
   Google Scholar
• Chen GT, Yang X, Ling Y, et al. Protopanoxadiol peroxide derivatives, and the preparation method and application thereof. CN102766184A; 2012
   Google Scholar
• Lou J, Zhang LQ, Zhang XQ. 20(S)-PPD derivative, its medical composition and application. CN1651451A; 2005
   Google Scholar
• Chen HL, Huang YM, Chang CT. Dicarboxylic acid ester derivatives of ginsenoside, pharmaceutical preparations containing the same, and preparation thereof. US0234956A1; 2006
   Google Scholar
• Hwan M, Yoon T. Treatment and prevention of cancer with new ginsenoside derivatives. WO116042A1; 2005
   Google Scholar
• Zheng YN, Liu FG, Zhang CZ, et al. Preparation of Ginsenoside rh2 fatty acid diester compounds as antitumor agents. CN102603848A; 2012
   Google Scholar
• Chen GT, Song Y, Yang X, et al. PPD derivative containing ethoxy side group, and its application in preparation of drug for treatment and/or prevention of tumor. CN103387596A; 2013
   Google Scholar
• Hu LH, Chen WT, Liu JH, et al. Protopanaxadiol derivative, its preparation method, and application. CN103570790A; 2014
   Google Scholar
• Kim YH, Kang HG, Hyun J H, et al. Antitumor activities of gypenosides. KR067807A; 2011
   Google Scholar
• Piao XL. Application of four kinds of gypenosides from Gynostemma pentaphyllum for preparing antitumor medicine. CN102579471A; 2012
   Google Scholar
• Woo SS, Kim DS, Do SG, et al. Pharmaceutical composition for preventing and treating diabetes or glucose control abnormality comprising ginsenosides. WO098604A1; 2006
   Google Scholar
• Zheng YN, Liu FG, Zhang CZ, et al. Application of ginsenosides and their fatty acid ester derivatives for treating diabetes mellitus. CN102600189A; 2012
   Google Scholar
• Li YX, Cheng NN, Li XP, et al. Preparation of dammarane glycoside for the treatment of diabetes. CN102796159A; 2012
   Google Scholar
• Hiroaki K. Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages. EP2517711; 2012
   Google Scholar
• Li PY, Su H, Liu HY, et al. The method of preparation and application of ocotillol R1. CN103193847A; 2013
   Google Scholar
• Hwang GS, Jung SJ, Lee HS, et al. Anti-obesity pharmaceutical composition containing processed Panax ginseng extract. KR099362A; 2008
   Google Scholar
• Sui DY, Chen YP, Yu XF, et al. Application of composition containing ginsenoside-Rb3 and ginsenoside-Rb2 to treatment of heart and cerebral vascular diseases. CN102920721A; 2012
   Google Scholar
• Kim BD, Lee JG, Kim SH, et al. Ginsenosides for preventing and treating thrombotic diseases. KR017062A; 2011
   Google Scholar
• Kim BD, Park JH, Yun-Choi HS, et al. Composition comprising ginsenosides isolated from the extract of processed ginseng for preventing and treating thrombotic disease. US0028467A1; 2010
   Google Scholar
• Ju DY, Chen YP, Yu XF, et al. The application of ginsenoside Rb3 in the medicine for preventing and treating myocardial remodeling. CN102775460A; 2012
   Google Scholar
• Gu Q, Sun DJ, Guo XP, et al. Medical composition for treating cerebral infarction. CN102085208A; 2011
   Google Scholar
• Liu L, He Q, Cheng YY, et al. Chinese medicine ext. derived from Panax notoginseng. CN101040885; 2007
   Google Scholar
• Wu XM. The application of Ginsenosides Rb1 in antihypertensive in human body. CN102920723A; 2012
   Google Scholar
• Wu XM. The application of Ginsenosides Re in antihypertensive in human body. CN102920724A; 2012
   Google Scholar
• Jo TH, Woo SS, Cha JM, et al. Composition comprising ginsenosides for treating or preventing angiostenosis and restenosis. WO120535A1; 2005
   Google Scholar
• Hwang GS, Lee HJ, Kim JH, et al. Processed Panax extracts for preventing and treating arteriosclerosis by inhibiting vascular smooth muscle cell proliferation and foam cell formation. KR066480A; 2014
   Google Scholar
• Li PY, Liu JP, Lu D, et al. Medicinal application of pseudo ginsenoside F11 to treatment and prevention of cardiovascular disease and cerebrovascular disease. CN101524358A; 2009
   Google Scholar
• Li PY, Liu JP, Tian X, et al. Method for extracting pseudoginsenoside RT5 from Panax quinquefolius saponins and medicinal application thereof. CN102010456A; 2011
   Google Scholar
• Liu JP, Li PY, Lu D, et al. Preparation of American ginseng extract F5ab and its pharmaceutical application for treating myocardial ischemia. CN101928320A; 2010
   Google Scholar
• Li PY, Liu JP, Lu CG, et al. 20(R)-pseudoginsenoside F11, and extraction method and medical application thereof. CN101967170A; 2011
   Google Scholar
• Yang SC, Shen Y, Li XB, et al. A pharmaceutical composition for treating myocardial ischemia and its application. CN104116750A; 2014
   Google Scholar
• Wang ZT, Gao B, Yang L, et al. The medical application of notoginsenoside Fc. CN103908460A; 2014
   Google Scholar
• Xu XD, Tian Y, Sun XB, et al. Preparation and application of dammarane type triterpenoid saponin compound. CN103804455A; 2014
   Google Scholar
• Kang JS, Yeo SJ, Jeong JH, et al. Composition for improving brain function and memory dysfunction comprising ginsenosides Rg5 and Rk1 by protecting nerve cells from neurotoxin caused by NMDA. KR063041A; 2006
   Google Scholar
• Kim SJ. Promoter for the production of hyaluronic acid containing ginsenoside compound k. US0160752A1; 2006
   Google Scholar
• Yang L, Liu Y, He KJ. Anti-aging medicine of ginsenoside. CN1795868A; 2006
   Google Scholar
• Gu Q, Sun DJ, Guo XP, et al. Pharmaceutical composition containing ginsenoside Rg1 and notoginsenoside R1 for treating senile dementia. CN102085209A; 2011
   Google Scholar
• Chen XC. New use of ginsenoside Rg1. CN101084909; 2007
   Google Scholar
• Zhang WS, Li Z. Application of notoginsenoside R1. CN103877107A; 2014
   Google Scholar
• Sun F, Zhang TP, Ma SG, et al. Usage of ocotillol in preparation of medicine for treating or preventing senile dementia. CN1762368; 2005
   Google Scholar
• Wang JH, Lu SF, Yang ZR. Use of protopanoxadiol derivative and protopanaxatriol derivative in drug preparation. WO117699A1; 2014
   Google Scholar
• Wang T, Zhang Y, Han LF, et al. Natural compound extracted from Panax ginseng or Panax notoginseng and extraction method thereof, and pharmaceutical composition containing the compound and application thereof. CN103450308A; 2013
   Google Scholar
• Kim TW, Chung SK. Compounds for treating Alzheimer’s disease and for inhibiting beta-amyloid peptide production. US0245465A1; 2005
   Google Scholar
• Landry DW, Kim TW, Deng SX. Preparation of steroid oligosaccharides for the treatment of Alzheimer’s disease by inhibiting β-amyloid peptide production. US0014704A1; 2006
   Google Scholar
• Guo ZR, Yuan YN. 20-O-glycosyl-20(S)-protopanaxadiol-like compounds for treating rheumatic arthritis and osteoarthritis and preparation method thereof. CN101781352A; 2010
   Google Scholar
• Hwang GS, Kim BD, Park JI, et al. Processed Panax extracts for treating and preventing bone metabolic disease. KR060837A; 2013
   Google Scholar
• Hwang GS, Kim BD, Park JI, et al. Health food containing processed Panax extract for alleviating and preventing osteoporosis. KR060838A; 2013
   Google Scholar
• Tian J. Application of ginsenoside Rd for inducing mesenchymal stem cell to be directionally differentiated in to hepatic cell in vitro. CN103045531A; 2013
   Google Scholar
• Yang SL. Ginsenosides in combination with Chinese medicines for treatment of hepatitis. CN1425383A; 2003
   Google Scholar
• Kim BD, Lee HJ, Kim JH, et al. Panax extracts for treating and preventing liver diseases. KR043767A; 2013
   Google Scholar
• Kim BD, Lee HJ, Kim JH, et al. Functional food containing processed Panax ginseng extract for liver protection. KR060436A; 2013
   Google Scholar
• Hu LH, Shen X, Jiang HL, et al. Application and medical composition of dammarane triterpene derivatives. CN101530419A; 2009
   Google Scholar
• Baek SH, Kang GS, Kim HY, et al. Drug composition containing dammarane compound for preventing and treating kidney diseases. KR109282A; 2007
   Google Scholar
• Kang KS, Kim SN, Lee W. Composition for preventing, improving, or treating renal disease including maillard browning reaction products of Panax species plant extract. US0178436A1; 2013
   Google Scholar
• Alkoclar EC, Yesil MA. composition for the treatment of chronic fatigue syndrome comprising 3,7-bis(2-hydroxyethyl)icaritin and ginsenoside RE. WO185871A1; 2014
   Google Scholar
• Fan FL, Huang YH, Wu YJ. New application of ginsenoside Rd in preparation of colitis treatment medicament. CN101791316A; 2010
   Google Scholar
• Kim DH, Han MJ, Han SY. Ginseng saponins and lactobacillus-fermented ginseng for the treatment of colitis. KR030025 A; 2007
   Google Scholar
• Bi Y, Xu JY, Zhang HY, et al. Dammarane type saponin derivatives useful in treatment of infection and their preparation. CN 103059088 A; 2013
   Google Scholar
• Xiang H, Liu XY, Zhang H, et al. Application of ginsenoside Rd to preparing anti-depression medicament. CN102138926A; 2011
   Google Scholar
• Xiang H, Liu YX, Zhang H, et al. Use of Ginsenosides Rg1 in the treatment of depressant. CN102125573A; 2011
   Google Scholar
• Wang JH, Lu SF, Xu CJ, et al. Applications of 20(S)-protopanaxadiol derivatives and 20(S)-protopanaxatriol derivatives in manufacture of antidepressants. CN103211823A; 2013
   Google Scholar
• Wang JH, Lu SF, Xu CJ, et al. Protopanoxadiol derivative useful in treatment of depression-type mental illness and its preparation. WO117700A1; 2014
   Google Scholar
• Jin FX, Yu HS. Panax ginseng saponin Rg2 series and Rh1 series, its preparation and application in anti-skin aging cosmetic. CN102302420A; 2012
   Google Scholar
• Kim SN, Kang BY, Kim S, et al. A composition containing ginsenoside F1 or compound K for skin external application. WO070436A1; 2005
   Google Scholar
• Yoo BH, Kang BY, Yeom MH. Nanoemulsion comprising metabolites of ginseng saponin as an active component and a method for preparing the same, and a skin-care composition for anti-aging containing the same. US0216261A1; 2006
   Google Scholar
• Kim BD, Park MG, Lee YB, et al. Functional health food comprising processed Panax ginseng extract for relieving skin wrinkles. KR059773A; 2013
   Google Scholar
• Kim BD, Park MG, Lee YB, et al. Health food containing extracts of processed Panax for inhibiting skin aging. KR059661 A; 2013
   Google Scholar
• Kim BD, Park MG, Lee YB, et al. Processed Panax extracts for relieving skin wrinkles. KR059772 A; 2013
   Google Scholar
• Kim BD, Park MG, Lee YB, et al. Food additive containing extracts of processed Panax for inhibiting skin aging. KR059660 A; 2013
   Google Scholar
• Kim BD, Song GC, Lee JY, et al. Cosmetic composition comprising extract of heat-processed Panax and showing skin anti-wrinkle activity. KR131784A; 2011
   Google Scholar
• Kim BD, Park MG, Lee YB, et al. Food additive comprising processed extract of Panax plant for relieving skin wrinkles. KR059774A; 2013
   Google Scholar
• Fumiyuki T. Cosmetic comprising Panax pseudoginseng Wall extract for improving skin elasticity. JP028150A; 2006
   Google Scholar
• Choi JH, Lee SM, Lim YH, et al. Ginsenoside RK3 for improving wrinkle. KR115476A; 2013
   Google Scholar
• Choi JH, Lee SM, Lim YH, et al. Ginsenoside Rh4 for preventing wrinkles. KR115477A; 2013
   Google Scholar
• Choi JH, Lee SM, Park YU, et al. Panaxatriol ginsenosides for preventing skin aging by inhibiting fibroblast collagenase activity. KR065163A; 2014
   Google Scholar
• Wang W, Zhao YQ, Rayburn ER, et al. In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol 2007;59(5):589-601
   Google Scholar
• Zhao JM, Li N, Zhang H, et al. Novel dammarane-type sapogenins from Panax ginseng berry and their biological activities. Bioorg Med Chem Lett 2011;21:1027-31
   PubMed Web of Science ®Google Scholar
• Wang P, Bi XL, Guo YM, et al. Semi-synthesis and anti-tumor evaluation of novel 25-hydroxyprotopanaxadiol derivatives. Eur J Med Chem 2012;55:137-45
   PubMed Web of Science ®Google Scholar
• Wang P, Bi XL, Yuan HN, et al. Synthesis and anti-tumor evaluation of novel 25-hydroxyprotopanaxadiol analogs incorporating natural amino acids. Steroids 2013;78(2):203-9
   Google Scholar